Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Kissei Pharmaceutical Co ( (JP:4547) ).
Kissei Pharmaceutical Co. announced an increase in its year-end dividend to ¥55 per share, reflecting a ¥10 rise from the previous forecast, resulting in an annual dividend of ¥100 per share. This decision is part of the company’s new mid-term management plan, ‘Beyond 80,’ which emphasizes shareholder returns, including a planned allocation of 57 billion yen for dividends and share buybacks over the next five years.
More about Kissei Pharmaceutical Co
Kissei Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and sale of pharmaceutical products. The company is listed on the Tokyo Stock Exchange and has been working on transitioning from a patent cliff to a growth phase.
Average Trading Volume: 72,057
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen160.2B
For detailed information about 4547 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue